ES2678049T3 - Anticuerpos monoclonales de unión a mcm5 - Google Patents

Anticuerpos monoclonales de unión a mcm5 Download PDF

Info

Publication number
ES2678049T3
ES2678049T3 ES16727798.7T ES16727798T ES2678049T3 ES 2678049 T3 ES2678049 T3 ES 2678049T3 ES 16727798 T ES16727798 T ES 16727798T ES 2678049 T3 ES2678049 T3 ES 2678049T3
Authority
ES
Spain
Prior art keywords
antibody
seq
sequence
mcm5
bind
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES16727798.7T
Other languages
English (en)
Spanish (es)
Inventor
Ronald Alfred Laskey
Kai Stoeber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arquer Diagnostics Ltd
Original Assignee
Arquer Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arquer Diagnostics Ltd filed Critical Arquer Diagnostics Ltd
Application granted granted Critical
Publication of ES2678049T3 publication Critical patent/ES2678049T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES16727798.7T 2015-06-08 2016-06-01 Anticuerpos monoclonales de unión a mcm5 Active ES2678049T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1509907.0A GB201509907D0 (en) 2015-06-08 2015-06-08 Antibodies
GB201509907 2015-06-08
PCT/GB2016/051609 WO2016198834A1 (en) 2015-06-08 2016-06-01 Monoclonal antibodies binding mcm5

Publications (1)

Publication Number Publication Date
ES2678049T3 true ES2678049T3 (es) 2018-08-08

Family

ID=53785114

Family Applications (1)

Application Number Title Priority Date Filing Date
ES16727798.7T Active ES2678049T3 (es) 2015-06-08 2016-06-01 Anticuerpos monoclonales de unión a mcm5

Country Status (8)

Country Link
US (2) US20180186892A1 (https=)
EP (1) EP3221352B1 (https=)
JP (3) JP2018520127A (https=)
CN (1) CN107810200B (https=)
ES (1) ES2678049T3 (https=)
GB (1) GB201509907D0 (https=)
TR (1) TR201808196T4 (https=)
WO (1) WO2016198834A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201509907D0 (en) * 2015-06-08 2015-07-22 Urosens Ltd Antibodies
GB201820868D0 (en) * 2018-12-20 2019-02-06 Arquer Diagnostics Ltd Detection method
GB201820867D0 (en) * 2018-12-20 2019-02-06 Arquer Diagnostics Ltd Detection method
GB201912605D0 (en) * 2019-09-02 2019-10-16 Arquer Diagnostics Ltd Cancer assay
CN118359714B (zh) * 2024-06-14 2024-10-22 浙江莱阅病理诊断科技有限公司 一种抗mcm2鼠单克隆抗体及其制备方法和免疫组化试剂的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000511291A (ja) * 1997-10-21 2000-08-29 キャンサー リサーチ キャンペーン テクノロジー リミティド 細胞の増殖異常の測定
WO2005026211A2 (en) * 2003-09-05 2005-03-24 Eli Lilly And Company Anti-ghrelin antibodies
GB0708002D0 (en) * 2007-04-25 2007-06-06 Univ Sheffield Antibodies
GB201509907D0 (en) * 2015-06-08 2015-07-22 Urosens Ltd Antibodies

Also Published As

Publication number Publication date
CN107810200A (zh) 2018-03-16
CN107810200B (zh) 2021-04-06
JP2020156486A (ja) 2020-10-01
EP3221352A1 (en) 2017-09-27
US20210277142A1 (en) 2021-09-09
EP3221352B1 (en) 2018-05-09
WO2016198834A1 (en) 2016-12-15
JP2018520127A (ja) 2018-07-26
GB201509907D0 (en) 2015-07-22
JP2022165963A (ja) 2022-11-01
US20180186892A1 (en) 2018-07-05
TR201808196T4 (tr) 2018-07-23

Similar Documents

Publication Publication Date Title
KR101147586B1 (ko) 결장직장암에 대한 마커로서 단백질 ｓ100ａ12 의 용도
ES2678049T3 (es) Anticuerpos monoclonales de unión a mcm5
US9429577B2 (en) Anti-uroplakin II antibodies systems and methods
JP6696896B2 (ja) 前立腺癌を検出する方法
US20220260588A1 (en) Methods and kits
KR20120041175A (ko) 미량 존재하는 인간 혈장 단백질 바이오마커의 신규 패널을 이용한 간성 섬유증의 임상적 진단
KR102047502B1 (ko) 포타슘 채널 단백질을 이용한 암 진단용 조성물
JP7156622B2 (ja) 前立腺癌検出のための組成物と方法
JP5660486B2 (ja) ムチン１（ｍｕｃ１）タンパク質に対する抗体及びその用途
ES2938313T3 (es) Uso de MCM5 como marcador para los cánceres ginecológicos
ES2776733T3 (es) Kit que comprende un anticuerpo que se une específicamente a la proteína del factor B del complemento y un anticuerpo que se une específicamente a la proteína del antígeno carbohidrato 19-9 para el diagnóstico del cáncer pancreático
KR20120095301A (ko) 항-사이토케라틴 8/18 복합체 자가면역항체를 포함하는 암 진단 마커 및 이의 항원을 포함하는 암 진단용 조성물
CN109517062A (zh) 能够结合linc00266-1多肽的抗体
ES3039453T3 (en) Use of bmmf1 rep protein as a biomarker for prostate cancer
KR101594287B1 (ko) 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트
CN110865184A (zh) Srsp蛋白和srsp抗原表位肽的应用及诊断和治疗肿瘤的产品
JP2024003567A (ja) 膵癌又は前立腺癌の診断を補助する方法及び膵癌又は前立腺癌の診断用試薬
ES2743508T3 (es) Métodos y productos para el diagnóstico y el pronóstico de la malignidad de tumores de ovario
WO2012077643A1 (ja) ｃｏｆｉｌｉｎ１タンパク質の免疫学的測定方法
HK1133295B (en) Use of protein s100a12 as a marker for colorectal cancer
WO2013181430A2 (en) Use of protein epitope of satb2 as an ihc marker for diagnosis and differential diagnosis of human gastrointestinal malignancies